- Home
- EVAX vs TOMZ Comparison
EVAX vs TOMZ Comparison
Compare EVAX & TOMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- TOMZ
- Stock Information
- Founded
- EVAX 2008
- TOMZ 1979
- Country
- EVAX Denmark
- TOMZ United States
- Employees
- EVAX N/A
- TOMZ N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- TOMZ Diversified Commercial Services
- Sector
- EVAX Health Care
- TOMZ Finance
- Exchange
- EVAX Nasdaq
- TOMZ Nasdaq
- Market Cap
- EVAX 16.3M
- TOMZ 15.7M
- IPO Year
- EVAX 2021
- TOMZ N/A
- Fundamental
- Price
- EVAX $1.64
- TOMZ $0.82
- Analyst Decision
- EVAX Strong Buy
- TOMZ Strong Buy
- Analyst Count
- EVAX 2
- TOMZ 1
- Target Price
- EVAX $10.00
- TOMZ $3.50
- AVG Volume (30 Days)
- EVAX 64.1K
- TOMZ 12.6K
- Earning Date
- EVAX 05-27-2025
- TOMZ 05-08-2025
- Dividend Yield
- EVAX N/A
- TOMZ N/A
- EPS Growth
- EVAX N/A
- TOMZ N/A
- EPS
- EVAX N/A
- TOMZ N/A
- Revenue
- EVAX $3,344,000.00
- TOMZ $8,201,313.00
- Revenue This Year
- EVAX $102.45
- TOMZ $9.68
- Revenue Next Year
- EVAX $100.30
- TOMZ $130.22
- P/E Ratio
- EVAX N/A
- TOMZ N/A
- Revenue Growth
- EVAX 4480.82
- TOMZ 19.09
- 52 Week Low
- EVAX $1.20
- TOMZ $0.60
- 52 Week High
- EVAX $20.81
- TOMZ $1.50
- Technical
- Relative Strength Index (RSI)
- EVAX 55.67
- TOMZ 52.35
- Support Level
- EVAX $1.42
- TOMZ $0.82
- Resistance Level
- EVAX $1.62
- TOMZ $0.89
- Average True Range (ATR)
- EVAX 0.11
- TOMZ 0.04
- MACD
- EVAX 0.03
- TOMZ 0.01
- Stochastic Oscillator
- EVAX 62.86
- TOMZ 51.86
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.